Search results
Results from the WOW.Com Content Network
The most common side effect is headache (about 8% of people taking it) and nausea, loss of appetite, weakness, rash and dizziness (each about 3%). [2] Common side effects (1/10 - 1/100) include: [2] General: weakness, fatigue, loss of appetite, headache, dizziness. Circulatory system: arrhythmia. Gastrointestinal: nausea, diarrhea, abdominal pain.
Low doses (50 mg or less) of hydrochlorothiazide as first‐line therapy for hypertension were found to reduce total mortality and cardiovascular disease events over a four-year study. [5] Hydrochlorothiazide appears be more effective than chlorthalidone in preventing heart attacks and strokes. [14] Hydrochlorothiazide is less potent but may be ...
Chlorothiazide, sold under the brand name Diuril among others, is an organic compound used as a diuretic and as an antihypertensive. [1] [2]It is used both within the hospital setting or for personal use to manage excess fluid associated with congestive heart failure.
It may be used if telmisartan by itself is not sufficient. [5] It is taken by mouth. [5] Common side effects include dizziness, upper respiratory tract infections, nausea, diarrhea, and tiredness. [2] Severe side effects may include kidney problems, electrolyte problems, and allergic reactions. [2] Use during pregnancy may harm the baby. [2]
Lighter Side. Medicare. News. Science & Tech. Shopping. Sports. Weather. ... 2024 at 12:45 AM. ... this is the latest addicting game to cross off your to-do list before a new one pops up 24 hours ...
Most of the drug excreted is unchanged, only small portion of the drug is metabolized to its inactive form 4-hydroxyvaleryl valsartan, the enzyme suspected to be responsible for this is the liver enzyme CYP2C9. [18] Hydrochlorothiazide has an oral bioavailability of 70% and reaches peak concentration around 1.5–2 hours following ingestion.
Weight loss with Ozempic or Wegovy requires an injection, but Pfizer is developing a similar drug in pill form. What to know about side effects, approval. Pfizer's twice-daily weight-loss pill ...
Despite the positive news of its weight loss results, Roche's stock took a hit last week — down 5.4% in the week — after concerns about the pill's side effects were revealed.